April 20, 2011 09:00 ET

Equity Research on Covance Inc. and Pharmaceutical Product Development Inc. -- Medical Researchers Positioned for Comeback in 2011

NEW YORK, NY--(Marketwire - Apr 20, 2011) - has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Medical Laboratories & Research industry and are offering free analytical research on Covance Inc. (NYSE: CVD) and Pharmaceutical Product Development Inc. (NASDAQ: PPDI). Register with us today at to have free access to this research or speak to one of our pros at

The medical laboratories and research industry has had a tough road during the recession. Reduced spending on drug development has hurt revenues for companies in the industry. Major drug makers have been preferring drugs already in the late stages of development or acquisitions to maintain their pipeline. Many drug trials were postponed or canceled as a result of this preference, damaging bottom-lines of drug developers. Get instant analyses of Covance Inc. and Pharmaceutical Product Development Inc. from live, real-time experts standing by at There is no commitment to join. is the Ultimate Trading Environment for investors. If you are considering owning Covance Inc. and Pharmaceutical Product Development Inc. then you should sign up for a free membership and our complimentary reports today at Over the last 5 years our returns outpaced any of the major indexes. Sign up today to find out what you are missing.

The industry could be ready for a bounce back this year, however, as trends may be changing. Early stage drug developers with long-term alliances may be better positioned than others to recover in 2011. Covance Inc. fared better than some developers during the recession thanks largely to several long-term partnerships. Spending is beginning to increase on early stage developments and Covance could be among several that are capable of widening margins this year. Covance Inc. report is accessible for free by registering today at

Pharmaceutical Product Development Inc. may similarly benefit from its recent inclusion to the Product Development Partners, a consortium of companies that develop medicine for poor populations. Pharmaceutical Product Development Inc. report is accessible for free by registering today at
Moving forward, while the industry as a whole has had a tough run over the last two years, spending does appear to be normalizing. Substantial gains may not be likely but the industry is moving in the right direction again through the first four months of 2011.

The two Medical Laboratories & Research stocks research reports are available for free by signing up now on


Shine's Room Online is the brain child of David Shine, a 15 year Wall Street veteran with a stellar track record. For 13 years Shine has trained thousands of traders to navigate and profit from the markets. Using cutting edge technology, Shine provides you with a community in which you can trade alongside Shine and his Team as they guide you through the market's ever-changing landscape.

To view our disclaimer, visit this link

Contact Information